Identification of actively translated mRNA transcripts in a rat model of early-stage colon carcinogenesis

Cancer Prevention Research

Volumn 2, Issue 11, 2009, Pages 984-994

  Davidson, Laurie A ^a   Wang, Naisyin ^a   Ivanov, Ivan ^b   Goldsby, Jennifer ^a   Lupton, Joanne R ^a   Chapkin, Robert S ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZOXYMETHANE; BETA CATENIN; CARCINOGEN; ICOSANOID; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOLIPASE A2; POLYUNSATURATED FATTY ACID; WNT PROTEIN; OMEGA 3 FATTY ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLON CANCER; COLON CARCINOGENESIS; COLON MUCOSA; CONTROLLED STUDY; DIET; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; MALIGNANT TRANSFORMATION; NONHUMAN; PRIORITY JOURNAL; RAT; RNA TRANSLATION; SIGNAL TRANSDUCTION; ANIMAL; CHEMICALLY INDUCED DISORDER; COLON TUMOR; ENZYME IMMUNOASSAY; GENE; GENE EXPRESSION PROFILING; GENETICS; MALE; METABOLISM; PATHOLOGY; PHYSIOLOGY; POLYSOME; PROTEIN SYNTHESIS; SPRAGUE DAWLEY RAT;

ANIMALS; AZOXYMETHANE; CARCINOGENS; COLONIC NEOPLASMS; FATTY ACIDS, OMEGA-3; GENE EXPRESSION PROFILING; GENES; IMMUNOENZYME TECHNIQUES; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYRIBOSOMES; PROTEIN BIOSYNTHESIS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER;

EID: 74049137195     PISSN: 19406207     EISSN: None     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-09-0144     Document Type: Article

References (50)

1. Prendergast GC. Signal transduction: putting translation before transcription. Cancer Cell 2003; 4:244-5.
2. Rajasekhar VK, Viale A, Socci ND, Wiedmann M, Hu X, Holland EC. Oncogenic ras and aktsignaling contribute to glioblastoma formation by differential recruitment of existing mRNAs to polysomes. Mol Cell 2003;12:889-901.
3. Spence J, Duggan BM, Eckhardt C, McClelland M, Mercola D. Messenger RNAs under differential translational control in Ki-ras-transformed cells. Mol Cancer Res 2006;4:47-60.
4. Xi Y, Shalgi R, Fodstad O, Pilpel Y, Ju Jingfang J. Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer. Clin Cancer Res 2006;12:2014-24.
5. Sebolt-Leopold JS, Dudley DT, Herrera R, et al. Blockade of MAP kinase pathway suppresses growth of colon tumors in vivo. Nature Med 1999; 5:810-6.
6. Ruggero D, Pandolfi PP. Does the ribosome translate cancer? Nature Rev Cancer 2003;3:179-92.
7. Bilanges B, Stokoe D. Mechanisms of translational deregulation in human tumors and therapeutic intervention strategies. Oncogene 2007;26: 5973-90.
8. Mikulits W, Pradet-Balade B, Habermann B, Beug H, Garcia-Sanz JA, Mullner EW. Isolation of translationally controlled mRNAs by differential screening. FASEB J 2000;14:1641-52.
9. Provenzani A, Fronza R, Loreni F, Pascale A, Amadio M, Quattrone A. Global alterations in mRNA polysomal recruitment in a cell model of colorectal cancer progression to metastasis. Carcinogenesis 2006;27:1323-33.
10. Anti M, Armelao F, Marra G, et al. Effects of different doses of fish oil on rectal cell proliferation in patients with sporadic colonic adenomas. Gastroenterology 1994;107:1709-18.
11. 2 release in healthy subjects. Gastroenterology 1993;105:1317-22.
12. Davidson LA, Nguyen DV, Hokanson RM, etal . Chemopreventive n-3 polyunsaturated fatty acids reprogram genetic signatures during colon cancer initiation and progression in the rat. Cancer Res 2004;64:6797-804.
13. Chang WC, Chapkin RS, Lupton JR. Predictive value of proliferation, differentiation and apoptosis as intermediate markers for colon tumorigenesis. Carcinogenesis 1997;18:721-30.
14. Ju J, Huang C, Minskoff SA, Mayotte JE, Taillon BE, Simons JF. Simultaneous gene expression analysis of steady-state and actively translated mRNA populations from osteosarcoma MG-63 cells in response to IL-1α via an open expression analysis platform. Nucleic Acids Res 2003;31: 5157-66.
15. Koenker R, Hallock K. Quantile Regression. J Econ Perspect2001;15:143-56
16. Bolstad BM, Irizarry RA, Astrand M, Speed TP. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003;19:185.
17. Storey D, Tibshirani R. Statistical significance for genome-wide studies. Proc Natl Acad Sci U S A 2003;100:9440-5.
18. Krichevsky AM, Kosik KS. Neuronal RNA granules: a link between RNA localization and stimulation-dependent translation. Neuron 2001;32:683-96.
19. Thomas JD, Johannes GJ. Identification of mRNAs that continue to associate with polysomes during hypoxia. RNA 2007;13:1-16.
20. Parkos CA, Colgan SP, Liang TW, etal. CD47 mediates post-adhesive events required for neutrophil migration across polarized intestinal epithelia. J Cell Biol 1996;132:437-50.
21. Nicolas F, Tiveron MC, Davoust J, Reggio H. GPI membrane anchor is determinant in intracellular accumulation of apical plasma membrane proteins in the non-polarized human colon cancer cell HT-29 18. J Cell Sci 1994;107:2679-89.
22. Perez R, Wu N, Klipfel AA, Beart BW. A better cell cycle target for gene therapy of colorectal cancer: cyclin G. J Gastrointest Surg 2003;7:884-9.
23. Chiao PJ, Hunt KK, Grau AM, etal. Tumor suppressor gene SMAD4/DPC4, its downstream target genes, and regulation of cell cycle. Ann NY Acad Sci 1999;880:31-7.
24. Kanagawa N, Niwa M, Hatanaka Y, et al. CCchemokine ligand 17 gene therapy induces tumor regression through augmentation of tumor-infiltrating immune cells in a murine model of preexisting CT26 colon carcinoma. Int J Cancer 2007;121:2013-22.
25. Grewal TS, Genever PG, Brabbs AC, Birch M, Skerry TM. Best5: a novel interferon-inducible gene expressed during bone formation. FASEB J 2000; 14:523-31.
26. Zhang R, Tian L, Chen LJ, etal. Combination of MIG (CXCL9) chemokine gene therapy with lowdose cisplastin improves therapeutic efficacy againstm urine carcinoma. Gene Ther 2006;13: 1263-71.
27. Subramanian A, Tamayo P, Mootha VK, et al. Gene setenrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 2005;102: 15545-50.
28. D'Errico I, Moschetta A. Nuclear receptors, intestinal architecture and colon cancer: an intriguing link. Cell Mol Life Sci 2008;65:1523-43.
29. Nandan MO, McConnell BB, Ghaleb AM, etal . Kruppel-like factor 5 mediates cellular transformation during oncogenic KRAS-induced intestinal tumorigenesis. Gastroenterology 2008;134:120-30.
30. Haigis KM, Kendall KR, Wang Y, etal. Differential effects of oncogenic K-Ras and N-Ras on proliferation, differentiation and tumor progression in the colon. Nat Genet 2008;40:600-8.
31. Buchanan FG, DuBois RN. Connecting Cox-2 and Wntin cancer. Cancer Cell 2006;9:6-8.
32. Komatsu K, Buchanan G, Katkuri S, et al. Oncogenic potential of MEK1 in rat intestinal epithelial cells in mediated via cyclooxygenase-2. Gastroenterology 2005;129:577-90.
33. Chang WC, Chapkin RS, Lupton JR. Fish oil blocks azoxymethane-induced tumorigenesis by increased cell Differentiation and apoptosis rather than decreased cell proliferation. J Nutr 1998;18: 351-7.
34. Crim KC, Sanders L, Hong MY, etal. Upregulation of p21waf1/cip1 expression in vivo by butyrate administration can be chemoprotective or chemopromotive depending on the lipid component of the diet. Carcinogenesis 2008;29:1415-20.
35. Mamane Y, Petroulakis E, Martineau Y, et al. Epigenetic activation of a subset of mRNAs by eIF4E explains its effects on cell proliferation. PLoS ONE 2007;2:e242.
36. Reddy BS, Burill C, Rigotty J. Effect of diets high in ω-3 and ω-6 fatty acids on initiation and postinitiation stages of colon carcinogenesis. Cancer Res 1991;51:487-91.
37. Yamada Y, Yoshimi N, Hirose Y, etal. Frequent β-catenin gene mutations and accumulations of the protein in the putative preneoplastic lesions lacking macroscopic aberrantcr ypt foci appearance, in ratcolon carcinogenesis. Cancer Res 2000;60: 3323-7.
38. Ahnen DJ. Are animal models of colon cancer relevantt o human disease. Dig Dis Sci 1985;30: 103-6S.
39. Ingolia NT, Ghaemmaghami S, Newman JRS, Weissman JS. Genome-wide analysis in vivo of translation with nucleotide resolution using ribosome profiling. Science 2009;324:218-23.
40. Palakurthi SS, Fluckiger R, Aktas H, et al. Inhibition of translation initiation mediates the anticancer effect of n-3 polyunsaturated fatty acid eicosapentaenoic acid. Cancer Res 2000;60:2919-25.
41. Lu X, de la Pena L, Barker C, Camphausen K, Tofilon PJ. Radiation-induced changes in gene expression involve recruitment of existing messenger RNAs to and away from polysomes. Cancer Res 2006;66:1052-61.
42. Gregorieff A, Clevers H. Wnts ignaling in the intestinal epithelium: form endoderm to cancer. Genes Dev 2005;19:877-90.
43. Araki Y, Okamura S, Hussain SP, etal. Regulation of cyclooxygenase-2 expression by the Wnt and Ras pathways. Cancer Res 2003;63:728-34.
44. Barker N, Clevers H. Tracking down the stem cells of the intestine: strategies to identify adult stem cells. Gastroenterology 2007;133:1755-60.
45. Femia AP, Dolara P, Giannini A, Salvadori M, Biggeri A, Caderni G. Frequent mutation of Apc gene in rat colon tumors and mucin-depleted foci, preneoplastic lesions in experimental colon carcinogenesis. Cancer Res 2007;67:445-9.
46. Lin J, Gan CM, Zhang X, etal. A multidimensional analysis of genes mutated in breast and colon colorectal cancers. Genome Res 2007;17:1304-18.
47. Connolly E, Braunstein S, Formenti S, Schneider RJ. Hypoxia inhibits protein synthesis through 4EBP1 and elongation factor 2 kinase pathway controlled by mTOR and uncoupled in breast cancer cells. Mol Cell Biol 2006;26:3955-65.
48. Shaw RJ, Cantley LC. Ras, PI([3])K and mTOR signaling controls tumour cell growth. Nature 2006;441:424-30.
49. Sabates-Beliver J, Van der Flier LG, de Palo M, eta l. Transcriptome profile of human colorectal adenomas. Mol Cancer Res 2007;5:1263-75.
50. Jones S, Chen WD, Parmigiani G, etal. Comparative lesion sequencing provides insights into tumor evolution. Proc Natl Acad Sci U S A 2008; 105:4283-8.